Collection 會議論文/會議摘要 [5/6] 期刊論文 [43/43] Siblings 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:10(20.41%) 含全文筆數:48(97.96%) 文件下載次數統計 下載大於0次:48(100.00%) 下載大於100次:45(93.75%) 檔案下載總次數:21385(0.40%) 最後更新時間: 2024-12-01 03:15 Top Upload Loading... Top Download Loading... Recent Submissions The mitochondrial stress signaling ... Crosstalk between FTH1 and PYCR1 dy... Tumor promoting effect of PDLIM2 do... Metastasis and immunosuppression pr... Mitochondrial Lon-induced mitophagy... Mitochondrial oxidative stress in t... A Fc-VEGF chimeric fusion enhances ... Lon upregulation contributes to cis... Sharpening up tumor microenvironmen... Insulin-like growth factor binding ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 49. (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page

Date	Title	Relation
2024-09-20	The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem	iScience. 2024 Sep 20;27(9):Article number 110710.
2024-09-18	Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells	Experimental and Molecular Medicine. 2024 Sep 18;56:2065-2081.
2024-06-17	Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1alpha activation	Journal of Experimental and Clinical Cancer Research. 2024 Jun 17;43:Article number 169.
2023-10	Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP beta-glucan in oral squamous cell carcinoma	Cancer Science. 2023 Oct;114(10):3857-3872.
2023-03-16	Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca2+-dependent FUNDC1 phosphorylation at the ER-mitochondria interface	Cell Death and Disease. 2023 Mar 16;14(3):Article number 199.
2023-02	A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment	Cancer Immunology Immunotherapy. 2023 Feb;72(2):351-369.
2022-09-26	Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?	Journal of Biomedical Science. 2022 Sep 26;29:Article number 74.
2022-09	Beta-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients	Oral Diseases. 2022 Sep;28(6):1484-149.
2022-05	Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide	Cancer Immunology, Immunotherapy. 2022 May;71(5):1115-1128.
2022-03-16	Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells	Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.

Showing items 1-10 of 49. (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page